Erweiterte Informationen für Ärzte


Pepin A et al.                    
Impact of Age on Patient-Reported Outcomes Following Stereotactic Body Radiation Therapy for Prostate Cancer.
Cureus. 2021;13(3):e13780. Published 2021 Mar 9. doi:10.7759/cureus.13780

Vlaskou B et al.                
Stereotactic radiotherapy for early stage non-small cell lung cancer: current standards and ongoing research.
Transl Lung Cancer Res. 2021;10(4):1930-1949. doi:10.21037/tlcr-20-860

Kinj R et al.                        
Stereotactic lung reirradiation for local relapse: A case series.
Clin Transl Radiat Oncol. 2021;28:85-87. Published 2021 Apr 5. doi:10.1016/j.ctro.2021.03.007

Long Y et al.                      
Therapeutic outcome and related predictors of stereotactic body radiotherapy for small liver-confined HCC: a systematic review and meta-analysis of observational studies.
Radiat Oncol. 2021;16(1):68. Published 2021 Apr 8. doi:10.1186/s13014-021-01761-1

Wolf F et al.                      
Ultrahypofractionation of localized prostate cancer : Statement from the DEGRO working group prostate cancer.
Strahlenther Onkol. 2021 Feb;197(2):89-96. doi: 10.1007/s00066-020-01723-8. Epub 2020 Dec 10. PMID: 33301049; PMCID: PMC7726607.

Buergy D et al.           
Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis
International journal of cancer  First published: 08 March 2021